Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics of Drugs Used in the Treatment of Cancers
Beata Franczyk, Jacek Rysz, Anna Gluba-Brzózka
Genes (2022) Vol. 13, Iss. 2, pp. 311-311
Open Access | Times Cited: 23

Showing 23 citing articles:

miRNA-Based Technologies in Cancer Therapy
Maria Pagoni, Claudia Cava, Diamantis C. Sideris, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1586-1586
Open Access | Times Cited: 37
Gene-environment interactions within a precision environmental health framework
Alison A. Motsinger‐Reif, David M. Reif, Farida S. Akhtari, et al.
Cell Genomics (2024) Vol. 4, Iss. 7, pp. 100591-100591
Open Access | Times Cited: 14
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
Sharon P. Shriver, Devon V. Adams, Brittany A. McKelvey, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 10, pp. 1181-1192
Open Access | Times Cited: 13
Preparation of a Novel Trimethoprim/Oxidized Pectin/Ti-MOF Nanoplymer as a Super Bioactive Agent
Ahmad Irfan, Munthar Kadhim Abosaoda, Anjan Kumar, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2025)
Closed Access | Times Cited: 1
SNPs in 3′UTR miRNA Target Sequences Associated with Individual Drug Susceptibility
Elena Y. Rykova, Nikita Ershov, Igor S. Damarov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13725-13725
Open Access | Times Cited: 30
Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?—A Review
Michał Wiciński, Anna Fajkiel-Madajczyk, Zuzanna Kurant, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1317-1317
Open Access | Times Cited: 6
Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy
Saud Alqahtani, Taha Alqahtani, Krishnaraju Venkatesan, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 535-535
Open Access
Application of dihydropyrimidine dehydrogenase deficiency testing for the prevention of fluoropyrimidine toxicity: a real-world experience in a Southern Italy cancer center
Gabriella Bianchino, A. Perrone, Donatella Lucchetti, et al.
Journal of Chemotherapy (2025), pp. 1-7
Closed Access
The role of UGT1A1 polymorphism in the management of colorectal cancer
Elham Babadi, Kamran Roudini, Kianmehr Aalipour, et al.
Oncology Reviews (2025) Vol. 19
Open Access
Association of HTR1A Gene Polymorphisms with Efficacy and Plasma Concentrations of Atypical Antipsychotics in the Treatment of Male Patients with Schizophrenia
Ying Qin, Jingwen Zhao, Yong Yang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 185-193
Open Access | Times Cited: 1
Enhancing breast cancer treatment through pharmacogenomics: A narrative review
Ram Mohan Ram Kumar, Suresh Joghee
Clinica Chimica Acta (2024) Vol. 562, pp. 119893-119893
Closed Access | Times Cited: 1
The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies
Samaneh Mollazadeh, Negar Abdolahzadeh, Meysam Moghbeli, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20652-e20652
Open Access | Times Cited: 3
Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib or Nilotinib in Iraqi Patients with Chronic Myeloid Leukemia: An Observational Study
Ekhlas Khammas Hasan, Ali A. Kasim, Bassam Francis Matti
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 215-221
Open Access
Pharmacogenomics and Precision Therapy in Prostate Cancer: Challenges and Perspectives
Nikola Stefanović
Prostate Cancer (2024), pp. 335-377
Closed Access
Role of Pharmacogenetics in Pharmacovigilance
Ruchika Sharma, Mukesh Nandave, Anoop Kumar
(2024), pp. 317-331
Closed Access
Genetic epidemiology in the era of genomic medicine
Siana Nkya
Elsevier eBooks (2024), pp. 207-223
Closed Access
The benefits of early psychiatric treatment in patients with oncological pathology
Cătălina Florina Florescu, Octavian Vasiliu, Dan Prelipceanu
Psihiatru ro (2024) Vol. 2, Iss. 77, pp. 11-11
Open Access
Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy
Luciana María Marangoni-Iglecias, Susana Rojo-Tolosa, Noelia Márquez-Pete, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8797-8797
Open Access
Reduce drug uptake in the development of resistance
Raquel Alves, Joana Jorge, Maria Inês Costa, et al.
Elsevier eBooks (2024), pp. 53-75
Closed Access
Implementing population pharmacogenomics: Tailoring drug therapy for diverse populations
Kariofyllis Karamperis, George P. Patrinos
Elsevier eBooks (2024), pp. 143-158
Closed Access
The Future of Pharmacogenomics Requires New Discoveries and Innovative Education
Emiliano Giardina, Stefania Zampatti
Genes (2022) Vol. 13, Iss. 9, pp. 1575-1575
Open Access | Times Cited: 1
TPMTgene polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a healthy Venezuelan population
Yuselin Mora, Cecilia Villegas, Yamile M Mora, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 4, pp. 219-225
Closed Access
Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration–Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia
Deema Adawi, Nadia Ben Fredj, Ahmad Al-barghouthi, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 49, Iss. 1, pp. 43-55
Closed Access
Pharmacogenetics in Cancer Drugs: Traditional Review
Esra Tekcan, Şengül TURAL
Journal of Literature Pharmacy Sciences (2022) Vol. 11, Iss. 3, pp. 213-220
Open Access
Page 1

Scroll to top